You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 139 No. 8, August 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (19)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Ophthalmology
 •Ophthalmological Disorders
 •External Eye Disease
 •Dermatology
 •Dermatologic Disorders
 •Bullous Diseases
 •Pemphigus
 •Immunology
 •Immunologic Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

VIGNETTES
Ocular Mucous Membrane Pemphigoid and Ocular Pemphigus Vulgaris Treated Topically With Tacrolimus Ointment

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

We report a case of mucous membrane pemphigoid and a case of ocular pemphigus vulgaris treated with tacrolimus ointment.

Report of Cases

Case 1. The patient is a 74-year-old woman with a 5-year history of ocular irritation. Examination revealed bilateral blepharitis, entropion, symblepharon, and mild conjunctivitis. Conjunctival biopsy results showed no significant histopathologic abnormality, but direct immunofluorescence revealed strong linear to shaggy deposition of fibrinogen at the basement membrane zone. Indirect immunofluorescence demonstrated positive staining (IgG) of the basement membrane zone at a titer of 1:40. She was treated with dexamethasone-tobramycin (TobraDex) ophthalmic ointment twice daily. After 4 weeks she was started on a trial of 0.03% tacrolimus ointment daily. She discontinued the dexamethasone-tobramycin treatment after 5 weeks, 1 week after beginning treatment with tacrolimus. Three months later, she was asymptomatic with no signs of inflammation in the eyes. She experienced no irritation from the tacrolimus and has been applying the medication for . . . [Full Text of this Article]


Comment
Virginia C. Hall, MD
Mayo Clinic
4500 San Pablo Rd
Jacksonville, FL 32224
(e-mail: Hall.Virginia@Mayo.edu)

Thomas J. Liesegang, MD; David A. Kostick, MD; Donald P. Lookingbill, MD
Jacksonville,



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.